Dempze Nancy E Thermo Fisher Scientific Inc. Transaction History

Dempze Nancy E

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$541.52 - $599.02 $10,830 - $11,980	20 Added 4.4%	475 $262,000
Q1 2024 May 13, 2024	SELL	$528.82 - $599.43 $3,172 - $3,596	-6 Reduced 1.3%	455 $264,000
Q3 2023 Nov 14, 2023	SELL	$498.29 - $574.41 $30,395 - $35,039	-61 Reduced 11.69%	461 $233,000
Q1 2023 May 10, 2023	SELL	$535.0 - $604.82 $2,140 - $2,419	-4 Reduced 0.76%	522 $300,000
Q4 2022 Feb 09, 2023	BUY	$484.71 - $571.37 $12,117 - $14,284	25 Added 4.99%	526 $289,000
Q4 2021 Feb 08, 2022	SELL	$569.0 - $667.24 $5,690 - $6,672	-10 Reduced 1.96%	501 $334,000
Q3 2021 Nov 10, 2021	SELL	$509.53 - $609.78 $2,547 - $3,048	-5 Reduced 0.97%	511 $292,000
Q2 2021 Aug 09, 2021	BUY	$441.0 - $508.24 $22,491 - $25,920	51 Added 10.97%	516 $261,000
Q1 2021 May 17, 2021	SELL	$439.85 - $518.83 $4,398 - $5,188	-10 Reduced 2.11%	465 $213,000
Q3 2020 Oct 28, 2020	BUY	$359.77 - $441.52 $170,890 - $209,722	475 New	475 $210,000

2,832

334M

2.37M

2.75M

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $201B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

Get notified when there are updates to the investment portfolio of Dempze Nancy E, based on Form 13F filings with the SEC.

Stay updated on Dempze Nancy E with notifications on news.